Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene van der Haar Àvila

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer Metastasis Reviews|June 2, 2023
Current state-of-the-art on ganglioside-mediated immune modulation in the tumor microenvironmentIrene van der Haar Àvila, Britt Windhouwer, Sandra J van Vliet
Methods in Molecular Biology (Clifton, N.J.)|January 23, 2019
Evaluating Antibody-Dependent Cell-Mediated Cytotoxicity by Chromium Release AssayIrene van der Haar Àvila, Patricia Marmol, Rolf Kiessling, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 23, 2019
Evaluating Antibody-Dependent Cell-Mediated Cytotoxicity by Flow CytometryIrene van der Haar Àvila, Patricia Marmol, Jeannette Cany, et al.
Oncoimmunology|September 17, 2020
PD-1 checkpoint blockade in advanced melanoma patients: NK cells, monocytic subsets and host PD-L1 expression as predictive biomarker candidatesYago Pico de Coaña, Maria Wolodarski, Irene van der Haar Àvila, et al.
European Journal of Immunology|May 19, 2026
Sialylation in Colorectal Cancer Rewires Antitumor Immunity at the Peritoneal Metastatic SiteIrene van der Haar Àvila, Kristiaan Lenos, Victor Lorrain, et al.
Cancers|September 15, 2020
FUT9-Driven Programming of Colon Cancer Cells towards a Stem Cell-Like StateAthanasios Blanas, Anouk Zaal, Irene van der Haar Àvila, et al.
Glycobiology|May 24, 2024
Limited impact of cancer-derived gangliosides on anti-tumor immunity in colorectal cancerIrene van der Haar Àvila, Tao Zhang, Victor Lorrain, et al.
International Journal of Cancer|July 7, 2025
Tumor desialylation surpasses anti-PD-L1 checkpoint therapy in restoring anti-tumor immunity in a murine model for colorectal cancerIrene van der Haar Àvila, Tao Zhang, Victor Lorrain, et al.
Journal for Immunotherapy of Cancer|November 8, 2023
Unraveling the impact of sialic acids on the immune landscape and immunotherapy efficacy in pancreatic cancerKelly Boelaars, Laura Goossens-Kruijssen, Di Wang, et al.
Cell Reports|November 17, 2021
Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8<sup>+</sup> T cellsElisa Matas-Rico, Elselien Frijlink, Irene van der Haar Àvila, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer Metastasis Reviews|June 2, 2023
Current state-of-the-art on ganglioside-mediated immune modulation in the tumor microenvironmentIrene van der Haar Àvila, Britt Windhouwer, Sandra J van Vliet
Methods in Molecular Biology (Clifton, N.J.)|January 23, 2019
Evaluating Antibody-Dependent Cell-Mediated Cytotoxicity by Chromium Release AssayIrene van der Haar Àvila, Patricia Marmol, Rolf Kiessling, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 23, 2019
Evaluating Antibody-Dependent Cell-Mediated Cytotoxicity by Flow CytometryIrene van der Haar Àvila, Patricia Marmol, Jeannette Cany, et al.
Oncoimmunology|September 17, 2020
PD-1 checkpoint blockade in advanced melanoma patients: NK cells, monocytic subsets and host PD-L1 expression as predictive biomarker candidatesYago Pico de Coaña, Maria Wolodarski, Irene van der Haar Àvila, et al.
European Journal of Immunology|May 19, 2026
Sialylation in Colorectal Cancer Rewires Antitumor Immunity at the Peritoneal Metastatic SiteIrene van der Haar Àvila, Kristiaan Lenos, Victor Lorrain, et al.
Cancers|September 15, 2020
FUT9-Driven Programming of Colon Cancer Cells towards a Stem Cell-Like StateAthanasios Blanas, Anouk Zaal, Irene van der Haar Àvila, et al.
Glycobiology|May 24, 2024
Limited impact of cancer-derived gangliosides on anti-tumor immunity in colorectal cancerIrene van der Haar Àvila, Tao Zhang, Victor Lorrain, et al.
International Journal of Cancer|July 7, 2025
Tumor desialylation surpasses anti-PD-L1 checkpoint therapy in restoring anti-tumor immunity in a murine model for colorectal cancerIrene van der Haar Àvila, Tao Zhang, Victor Lorrain, et al.
Journal for Immunotherapy of Cancer|November 8, 2023
Unraveling the impact of sialic acids on the immune landscape and immunotherapy efficacy in pancreatic cancerKelly Boelaars, Laura Goossens-Kruijssen, Di Wang, et al.
Cell Reports|November 17, 2021
Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8<sup>+</sup> T cellsElisa Matas-Rico, Elselien Frijlink, Irene van der Haar Àvila, et al.
Pageof 1